Blue Jet Healthcare Limited IPO
Basic information about the company: Blue Jet Healthcare's journey began in 1968, and since then, they have been at the forefront of innovation in the pharmaceutical and healthcare industry. They initially gained recognition as the pioneers in manufacturing saccharin and artificial sweeteners in India, a testament to their commitment to meeting diverse consumer needs. Blue Jet Healthcare is a versatile company, dealing in three primary product categories: 1. Contrast Media Intermediates: Blue Jet Healthcare is a leading player in the production of contrast media intermediates. These intermediates are essential components used in the field of medical imaging, particularly in CT scans and MRIs. 2. High-Intensity Sweeteners: As the first manufacturer of saccharin in India, Blue Jet Healthcare continues to contribute to the production of high-intensity sweeteners. These sweeteners play a crucial role in the food and beverage industry, providing low-calorie alternatives to sugar. 3. Pharma Intermediates and Active Pharmaceutical Ingredients: Blue Jet Healthcare's product portfolio extends to pharma intermediates and active pharmaceutical ingredients. Their involvement in this category reflects their dedication to ensuring the availability of quality pharmaceutical components. The core strengths of Blue Jet Healthcare are the pillars on which their success stands. These include:
Huge Manufacturing Capacity: The company boasts a significant manufacturing capacity for contrast media intermediates in India. This capacity ensures a consistent supply of critical healthcare components.
Niche Market: Blue Jet Healthcare operates in a niche market with high entry barriers. This positioning insulates the company from intense competition and secures its market share.
Long-Term Relationships: The company has fostered enduring relationships and long-term contracts with multinational customers. These partnerships are a testament to the trust and reliability Blue Jet Healthcare offers.
Promoter Holding
The promoters of Blue Jet Healthcare are Akshay Bansarilal Arora, Shiven Akshay Arora, and Archana & Akshay Arora. Their significant pre-issue shareholding stands at 100%, and even post-issue, they retain a substantial 86% shareholding, demonstrating their unwavering commitment to the company's growth.
Blue Jet Healthcare Ltd: Key IPO Details
IPO Dates: 25 to 27 Oct 2023
Price Range: ₹329 to ₹346 per share
Lot Size: 43 Shares
Issue Size: 840 Crs
Allotment Date: 1st or 2nd Nov 2023
Listing Date: 6th Nov 2023
GMP: +5% (only for information)
Allotment Link :
Join our WhatsApp Group for Trading/Investment ideas & Market Updates👇
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor before making any actual investment decisions, based on the information published here. Any reader taking decisions based on any information published here does so entirely at their own risk. Investors should bear in mind that any investment in the stock market is subject to unpredictable market-related risks. The author has no plans to invest in this offer and also the author does not recommend investing in any offer published on this website.